BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med (Lausanne) 2021;8:765474. [PMID: 34988090 DOI: 10.3389/fmed.2021.765474] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Astore C, Nagpal S, Gibson G. Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease. IJMS 2022;23:14380. [DOI: 10.3390/ijms232214380] [Reference Citation Analysis]
2 Vaghari-tabari M, Alemi F, Zokaei M, Moein S, Qujeq D, Yousefi B, Farzami P, Hosseininasab SS. Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects? Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2139222] [Reference Citation Analysis]
3 Kim HJ, Kim B, Lee MR, Ra M, Lee Y. Bamboo Shoot and Artemisia capillaris Extract Mixture Ameliorates Dextran Sodium Sulfate-Induced Colitis. Curr Issues Mol Biol 2022;44:5086-103. [PMID: 36286060 DOI: 10.3390/cimb44100345] [Reference Citation Analysis]
4 Vafaei SY, Abdolghaffari AH, Mahjub R, Eslami SM, Esmaeili M, Abdollahi M, Atyabi F, Dinarvand R, Ahad A. Budesonide-Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/7776092] [Reference Citation Analysis]
5 Ali S, Paul S, Yakkali S, Teresa Selvin S, Thomas S, Bikeyeva V, Abdullah A, Radivojevic A, Abu Jad AA, Ravanavena A, Ravindra C, Igweonu-nwakile EO, Hamid P. Glucocorticoids-Induced Neuropsychiatric Disorders in Patients With Inflammatory Bowel Disease: A Systematic Review. Cureus 2022. [DOI: 10.7759/cureus.28981] [Reference Citation Analysis]
6 Abdulla M, Mohammed N. A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances. BTT 2022;Volume 16:129-140. [DOI: 10.2147/btt.s380027] [Reference Citation Analysis]
7 Stange EF. Current and future aspects of IBD research and treatment: The 2022 perspective. Front Gastroenterol 2022;1. [DOI: 10.3389/fgstr.2022.914371] [Reference Citation Analysis]
8 Hu Y, Jin X, Gao F, Lin T, Zhu H, Hou X, Yin Y, Kan S, Chen D. Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front Microbiol 2022;13:955112. [DOI: 10.3389/fmicb.2022.955112] [Reference Citation Analysis]
9 Sudhakar P, Keersmaekers B, Stiers R, De Dycker E, Geens P, Paps A, Lambrechts T, Wellens J, Sabino J, Ferrante M, Vermeire S, Verstockt B, Limdi JK. Profiling the Use of Complementary Alternative Medicines among Inflammatory Bowel Disease Patients: Results from a Single Center Survey. GastroHep 2022;2022:1-10. [DOI: 10.1155/2022/9919542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Alharbi O, Aljebreen AM, Azzam NA, Almadi MA, Saeed M, Hajkhdermullaissa B, Asiri H, Almutairi A, Alruthia Y. Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study. JCM 2022;11:4157. [DOI: 10.3390/jcm11144157] [Reference Citation Analysis]
11 Elhag DA, Kumar M, Saadaoui M, Akobeng AK, Al-mudahka F, Elawad M, Al Khodor S. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. IJMS 2022;23:6966. [DOI: 10.3390/ijms23136966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Dang AK, Gonzalez DA, Kumar R, Asif S, Bali A, Anne KK, Konanur Srinivasa NK. Vinculum of Cardiovascular Disease and Inflammatory Bowel Disease: A Narrative Review. Cureus 2022. [DOI: 10.7759/cureus.26144] [Reference Citation Analysis]
13 Toskas A, Akbar A. IBD therapeutics: what is in the pipeline? Frontline Gastroenterol 2022;13:e35-43. [DOI: 10.1136/flgastro-2022-102130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Herrera-Gómez RG, Grecea M, Gallois C, Boige V, Pautier P, Pistilli B, Planchard D, Malka D, Ducreux M, Mir O. Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease. Cancers (Basel) 2022;14:2914. [PMID: 35740579 DOI: 10.3390/cancers14122914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kofla-Dłubacz A, Akutko K, Krzesiek E, Jamer T, Braksator J, Grębska P, Pytrus T, Stawarski A. Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases. J Clin Med 2022;11:994. [PMID: 35207271 DOI: 10.3390/jcm11040994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]